[ Price : $8.95]
Merck KGaA and Pfizer report that the Phase 3 JAVELIN gastric cancer trial did not meet its primary endpoint of superior overall s...[ Price : $8.95]
Federal Register notice: FDA determines the regulatory review period for patent extension purposes for Relypsas Veltassa (patirome...[ Price : $8.95]
An FDA webinar explains the principles underlying two new final guidances on when to submit a new 510(k) for changes to a medical ...[ Price : $8.95]
FDA releases the FDA-483 issued following an inspection at Northridge Hospital Dignity Health sterile drug products production fac...[ Price : $8.95]
The HHS Inspector General has withdrawn a favorable advisory opinion for the Caring Voice Coalition funded by drug companies to he...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Select Updates for Recommendations for Clinical Laboratory ...[ Price : $8.95]
Rep. Louise Slaughter (D-NY) urges FDA to take stronger action to preserve the effectiveness of antibiotics and protect public hea...[ Price : $8.95]
Pew Charitable Trusts public health director Elizabeth Jungman says progress has been made under the Drug Quality and Security Act...